Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population

Description

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Study Start Date

January, 15 2018

Estimated Completion Date

June 2019

Interventions

  • Device: A-CHESS

Study ID

New York Presbyterian Hospital -- 1704018122

Status

Unknown

Trial ID

NCT03388320

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

30

Sponsor

New York Presbyterian Hospital

Inclusion Criteria

  • Alcoholic liver disease
  • Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center
  • English speaking
  • Access to a smartphone

Exclusion Criteria

  • Unable to consent
  • Primary language other than English
  • No access to a smartphone

Gender

All

Ages

18 Years to 80 Years

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
New York Presbyterian Hospital Weill Cornell Medicine and Columbia University Medical Center - New York, New York 48.5 miles Nicole T Shen MD 314-609-5911 nts9004@nyp.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.